Literature DB >> 15558152

Clinical and laboratory aspects of common variable immunodeficiency.

Cristina M Kokron1, Paolo R Errante, Myrthes T Barros, Gisele V Baracho, Maristela M Camargo, Jorge Kalil, Luiz V Rizzo.   

Abstract

Common variable immunodeficiency (CVID) is an immunological disorder characterized by defective antibody production, recurrent infections, most notably of the respiratory tract, autoimmune phenomena and cancer. Some CVID patients may also present disturbances of the cellular immune response such as a decrease in the number and proportion of different lymphocyte populations, diminished lymphoproliferative response to mitogens and antigens, altered production of cytokines, and deficient expression of cell-surface molecules. Most Brazilian CVID patients included in this study show a decrease in T and B lymphocyte counts in the peripheral blood. Furthermore, their lymphocytes are more susceptible to apoptosis following activation than normal individuals, and they have a decrease in the expression of activation molecules like CD25, CD69, CD40L and CD70. Moreover, they show a decreased synthesis of IL-4 and IL-5 in comparison with normal individuals. The increase in susceptibility to apoptosis following activation, may also be responsible for the decrease in the expression of activation molecules and CD40L, decrease in Th2 cytokines synthesis, and in the number of T and B circulating cells. In this study we discuss some of these immunological disturbances correlating them to the patients' clinical features and comparing our patients' findings to the literature.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15558152     DOI: 10.1590/s0001-37652004000400007

Source DB:  PubMed          Journal:  An Acad Bras Cienc        ISSN: 0001-3765            Impact factor:   1.753


  15 in total

Review 1.  Autoimmune Cytopenias in Common Variable Immunodeficiency Are a Diagnostic and Therapeutic Conundrum: An Update.

Authors:  Sanchi Chawla; Prabal Barman; Rahul Tyagi; Ankur Kumar Jindal; Saniya Sharma; Amit Rawat; Surjit Singh
Journal:  Front Immunol       Date:  2022-06-20       Impact factor: 8.786

2.  Bronchiectasis caused by common variable immunodeficiency.

Authors:  Paulo Henrique do Amor Divino; José Henrique de Carvalho Basilio; Renato Moraes Alves Fabbri; Igor Polônio Bastos; Wilma Carvalho Neves Forte
Journal:  J Bras Pneumol       Date:  2015 Sep-Oct       Impact factor: 2.624

3.  Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID).

Authors:  Lilit Garibyan; Adrian A Lobito; Richard M Siegel; Matthew E Call; Kai W Wucherpfennig; Raif S Geha
Journal:  J Clin Invest       Date:  2007-05-10       Impact factor: 14.808

Review 4.  Autoimmunity in common variable immunodeficiency.

Authors:  Susana Lopes-da-Silva; Luiz Vicente Rizzo
Journal:  J Clin Immunol       Date:  2008-04-29       Impact factor: 8.317

5.  TACI, isotype switching, CVID and IgAD.

Authors:  Emanuela Castigli; Raif S Geha
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

6.  Increased serum levels of soluble CD30 in patients with common variable immunodeficiency and its clinical implications.

Authors:  Nima Rezaei; Mostafa Haji-Molla-Hoseini; Asghar Aghamohammadi; Ali Akbar Pourfathollah; Mina Moghtadaie; Zahra Pourpak
Journal:  J Clin Immunol       Date:  2007-10-03       Impact factor: 8.317

7.  Genetic polymorphism study of regulatory B cell molecules and cellular immunity function in an adult patient with Common Variable Immunodeficiency.

Authors:  A Sarantopoulos; K Tselios; P Skendros; D Bougiouklis; I Theodorou; P Boura
Journal:  Hippokratia       Date:  2008-07       Impact factor: 0.471

Review 8.  Cytokines in common variable immunodeficiency as signs of immune dysregulation and potential therapeutic targets - a review of the current knowledge.

Authors:  Farnaz Najmi Varzaneh; Bärbel Keller; Susanne Unger; Asghar Aghamohammadi; Klaus Warnatz; Nima Rezaei
Journal:  J Clin Immunol       Date:  2014-05-15       Impact factor: 8.317

Review 9.  Difficult-to-control asthma management through the use of a specific protocol.

Authors:  Pedro Giavina-Bianchi; Marcelo Vivolo Aun; Carla Bisaccioni; Rosana Agondi; Jorge Kalil
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

10.  Analysis of the sputum and inflammatory alterations of the airways in patients with common variable immunodeficiency and bronchiectasis.

Authors:  Andrea Cristina Pereira; Cristina M Kokron; Beatriz Mangueira Saraiva Romagnolo; Claudia Simeire Albertini Yagi; Paulo Hilário Nascimento Saldiva; Geraldo Lorenzi Filho; Elnara Marcia Negri
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.